New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2012
21:01 EDTAAPL, BLK, VIAB, VIA, GD, WDC, BKS, NVS, RDSA, JPM, MPCApple, Shell, JPMorgan, and others are sound investments in 2013, Barron's says
Due to market uncertainty investors should look toward well-run companies. As such, Apple (AAPL), Royal Dutch Shell (RDSA), JPMorgan Chase (JPM), Novartis (NVS), General Dynamics (GD), Barnes & Noble (BKS), Western Digital (WDC), BlackRock (BLK), Viacom (VIA, VIAB), and Marathon Petroleum (MPC) were named favorite stocks for 2013, Barron's contends in its cover story. All of the aforementioned stocks could produce 15%-20% returns in 2013, the paper adds. Reference Link
News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Check below for free stories on AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
August 13, 2014
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:41 EDTBLKBlackRock among firms contacted by SEC about alternative mutual funds, WSJ says
Subscribe for More Information
07:22 EDTBLKBlackRock management to meet with UBS
Meeting to be held in New York on August 13 hosted by UBS.
07:19 EDTAAPLSiri creators working on new advanced AI system, Wired reports
Subscribe for More Information
06:19 EDTJPMBanks pressing Federal Reserve to delay rule on investments, WSJ says
Banks are pushing U.S. policy makers for a delay of a rule that requires them to sell investments in private-equity and venture-capital funds, reports the Wall Street Journal. According to people familiar with the effort, bank officials, trade groups and lawmakers are lobbying the Federal Reserve to delay the rule for up to seven years that limits banks' investments. Reference Link
August 12, 2014
16:00 EDTAAPLOptions Update; August 12, 2014
iPath S&P 500 VIX Short-Term Futures down 20c to 31.65. Option volume leaders: AAPL MNKD TWTR TSLA KMI KATE MGM NFLX KO according to Track Data.
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
07:48 EDTJPMBanks posted second-highest profit in 23 years in second quarter, WSJ says
Subscribe for More Information
06:24 EDTAAPLApple readies Healthkit launch despite complicated regulations, Reuters says
Subscribe for More Information
06:19 EDTAAPLApple suppliers begin production of next-generation iPads, Bloomberg says
Apple suppliers began production of next-generation iPads as the tech firm looks to reignite the popularity of tablet computers after it experienced two consecutive quarters of sales declines, according to Bloomberg, citing people with knowledge of the matter. Reference Link
05:47 EDTAAPLApple December quarter margins likely down sequentially, says Piper Jaffray
Piper Jaffray says itís likely that Apple's December quarter margins decline quarter-over-quarter due to the impact of the updated iPhone 6. Piper does not view the potential margin decline as a long-term negative, however, noting that Apple showed with the iPhone 5S that margins can expand as the company moves away from new design launches. Piper says it remains a buyer of Apple shares with an Overweight rating and $105 price target.
August 11, 2014
16:27 EDTJPMJPMorgan to sell 50% of portfolio companies held by One Equity Partners
Subscribe for More Information
16:00 EDTAAPLOptions Update; August 11, 2014
iPath S&P 500 VIX Short-Term Futures down 1.33 to 31.90. Option volume leaders: AAPL KMI MNKD PBR AMZN SCTY TWTR TSLA according to Track Data.
14:58 EDTJPMJPMorgan to sell about half of One Equity Partners pe unit, DJ says
JPMorgan plans to sell about $2B in portfolio companies of One Equity and retain ownership of roughly half of portfolio companies, said Dow Jones, citing sources.
10:07 EDTAAPLVirnetX says court denies Apple motion in patent suit
VirnetX (VHC) announced that on August 8 the U.S. District Court for the Eastern District of Texas, Tyler Division, issued its patent claim construction, or "Markman" Order and ruled on a VirnetX motion in the ongoing patent infringement action between VirnetX and Apple (AAPL). Both parties had presented arguments on the disputed terms along with various other motions at a Markman hearing on May 20. In the Markman order, the court denied Apple's Motion for Summary Judgment of Indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by VirnetX were invalid for indefiniteness. In a separate order, the court granted in part and denied in part VirnetX's Motion for Partial Summary Judgment on Apple's Invalidity Counterclaims. The court's order precludes Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in VirnetX's prior litigation against Apple. Apple is not precluded from asserting invalidity as a defense against infringement of the claims that were not tried before a jury in the Apple I case. "We are extremely pleased with the court's rulings and we remain confident in the merits of our complaint against Apple," said Kendall Larsen, VirnetX CEO and President. "We believe the court's Markman Order and motion ruling represents another significant step towards the successful resolution of this litigation."
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
06:23 EDTAAPLGoogle testing "Listen Now" music ads, WSJ reports
Subscribe for More Information
05:18 EDTNVSNovartis reports LCZ696 significantly reduced cardiovascular deaths
New data revealing the reduction in cardiovascular, or CV, deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction, or HF-REF, will be presented at the European Society of Cardiology, or ESC, Congress 2014. The 8,442 patient study, PARADIGM-HF, was specifically designed to see if LCZ696 could increase survival over and above what can be achieved with ACE-inhibitor enalapril in addition to current best treatment in HF-REF patients. In March the Data Monitoring Committee overseeing the study confirmed those given LCZ696 were significantly less likely to die from CV causes, leading to the trial being closed early. LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF. PARADIGM-HF is the largest heart failure study ever conducted and was stopped early in March due to compelling efficacy. LCZ696 was recently granted FDA Fast Track status and rolling submission expected to be complete by end of year.
August 10, 2014
17:04 EDTVIA, VIABParamount's 'Teenage Mutant Ninja Turtles' tops weekend box office, WSJ says
Paramount Pictures' (VIA,VIAB) "Teenage Mutant Ninja Turtles" edged out Disney's (DIS) "Guardians of the Galaxy," opening to an estimated $65M in the U.S. and Canada, says the Wall Street Journal. Reference Link
16:51 EDTAAPLCourt rejects $324M settlement in tech hiring conspiracy, NYT says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use